Allergy and Immunology News of the Day

Partial improvement of solar urticaria after omalizumab.

http://www.ncbi.nlm.nih.gov/pubmed/20159260?dopt=Abstract

Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions.

http://www.ncbi.nlm.nih.gov/pubmed/20159266?dopt=Abstract

Remission of asthma in adolescence is infrequent and not affected by 4 years of anti-inflammatory controller therapy. Factors such as sensitization and exposure, low lung function, and airway greater hyperresponsiveness decrease the likelihood of remitting asthma.

http://www.ncbi.nlm.nih.gov/pubmed/20159245?dopt=Abstract

Role of pharmacogenomics in improving the management of asthma. There is a large amount of interindividual variability in both therapeutic and adverse responses to asthma therapies. Genetic variability can account for 50% to 60% of this variability.

http://www.ncbi.nlm.nih.gov/pubmed/20159237?dopt=Abstract

Infants with eczema are at increased risk for mental health problems at age 10 years." Even if cleared afterward, eczema at age 1 to 2 years may cause persistent emotional and behavioral difficulties. http://www.ncbi.nlm.nih.gov/pubmed/20159252?dopt=Abstract

Infant eczema with concurrent sleeping problems appears to be a risk factor for the development of mental health problems. http://goo.gl/5AVv

No comments:

Post a Comment

Blog Widget by LinkWithin